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Summary Minimizing the time between efﬁcacy studies and public health action is impor-
tant to maximize health gains. We report the rationale, development and implementation of a
district-based strategy for the implementation of intermittent preventive treatment in infants
(IPTi) for malaria and anaemia control in Tanzania. From the outset, a research team worked
with staff from all levels of the health system to develop a public-health strategy that could
continue to function once the research team withdrew. The IPTi strategy was then implemented
by routine health services to ensure that IPTi behaviour-change communication materials were
available in health facilities, that health workers were trained to administer and to document
doses of IPTi, that the necessary drugs were available in facilities and that systems were in
place for stock management and supervision. The strategy was integrated into existing systems
as far as possible and well accepted by health staff. Time-and-motion studies documented that
IPTi implementation took a median of 12.4min (range 1.6—28.9) per nurse per vaccination
clinic. The collaborative approach between researchers and health staff effectively translated
research ﬁndings into a strategy ﬁt for public health implementation.
© 2008 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights
reserved.
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. Introduction
alaria remains a major challenge in many developing coun-
ries, with recent estimates of the annual number of deaths
irectly due to malaria of over 800 000, mainly in chil-
ren under 5 years living in Africa.1 Renewed focus and
esources are being paid to malaria prevention and treat-
ent in Africa, with major investment into the development
nd testing of antimalarial drugs and a malaria vaccine.
owever, there has been less investment in ensuring effec-
ive systems exist for the delivery of these new, and even
xisting, products.2,3
Intermittent preventive treatment in infants (IPTi) is a
romising tool to ﬁght malaria in children aged under 1 year.
PTi consists of the delivery of three treatment doses of an
ntimalarial drug alongside routine vaccinations. Most expe-
ience has been gained with sulfadoxine—pyrimethamine
SP), which has been licensed for use in children for over
0 years. Doses of IPTi are given as directly observed ther-
py (DOT) alongside routine vaccinations against DPT/OPV
at about 2—3 months of age) and measles (about 9 months
f age). IPTi is given regardless of the presence of symp-
oms or parasitaemia. An initial study in Ifakara, southern
anzania, showed that IPTi with SP was safe and reduced
he incidence of clinical malaria and severe anaemia by at
east 50% in the ﬁrst year of life.4 In recent years clinical
rials have been conducted In a range of other settings to
xplore the potential value of IPTi more broadly,5—10 and a
esearch consortium is generating additional data to inform
olicy-makers.11 The new emphasis on the global research
genda to work on operational feasibility of interventions
s a catalyst to undertaking effectiveness studies.12—16 In
outhern Tanzania, where initial safety and efﬁcacy data
lready exists, it has been possible to address operational
ssues surrounding the deployment of IPTi through routine
ealth systems.
The challenge of delivering efﬁcacious tools to their tar-
et group is increasingly recognized.17 The translation of
ositive research results into policy and then public health
ction often follows a stuttering and uncertain path. For
xample, the ﬁrst evidence of an impact of insecticide-
reated mosquito nets (ITNs) on child survival was published
n 1991,12 and further evidence followed from a coordi-
ated series of randomized trials.14,16,18—20 However, the
002 African Malaria Report showed that less than 2% of
frican children were using ITNs.21 The delivery of ITNs
equires the establishment of a novel delivery strategy and is
ore complex than vaccination-linked interventions. How-
ver, even interventions delivered alongside the Expanded
rogramme on Immunization (EPI) vaccines may face prob-
ems: vitamin A supplementation at the time of vaccination
gainst measles was made policy in Tanzania in 1987, yet
overage in the target group 12 years later was only 14%.22
esearch into optimizing delivery strategies, exploring oper-
tional feasibility, acceptability, cost and cost-effectiveness
nder real-life, district-based programme conditions should
ccelerate the process of moving from efﬁcacy to public
ealth action.
This paper describes our approach to the development
f an IPTi strategy that could be integrated into the Tanza-
ian EPI. The strategy involved development of an approach
ncluding behaviour-change communication messages and
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aterials, a training curriculum for health workers, adminis-
rative systems for SP supply and accountability and systems
o enable supervision and support at district and regional
evels.
. Methods and results
.1. Study area
he IPTi strategy was developed for initial implementation
n ﬁve districts in the Lindi (Lindi Rural, Nachingwea and
uangwa) and Mtwara (Newala and Tandahimba) regions of
outhern Tanzania. These districts are part of the south-
rn zone, which has the highest child mortality in Tanzania:
he under-ﬁve mortality rate was reported as 153/1000 live
irths in the ten-year period preceding the 2004/5 survey.23
he total population is around 900 000.24 Described in detail
lsewhere,25 the area is largely low lying with a broad mix
f ethnic groups, although Swahili is widely spoken. Most
eople live in mud-walled, grass-roofed houses and depend
n subsistence farming, ﬁshing or small-scale trading for
heir livelihood. Most rural roads are unpaved, many becom-
ng impassable during the rainy seasons. The public health
ystem comprises a network of dispensaries, health centres
nd hospitals. Malaria is the leading public health problem
ccording to regional health reports.
.2. The approach to strategy development
e were keen to develop a strategy that could reason-
bly be expected to be implemented by the Ministry of
ealth (MoH) on withdrawal of the research team. Hence,
rom the beginning the researchers worked in partner-
hip with MoH policy-makers, managers and implementers
t all levels, and involved a large number of in-country
takeholders. Figure 1 shows the approach to the develop-
ent and implementation of IPTi, giving the main activities
ndertaken, timeline and stakeholders’ involvement and
nteractions. The initial phase of sensitization and develop-
ent of the strategy took approximately 1 year. However,
he aim to minimize the time gap between demonstration
f beneﬁts and implementation in practice relates to pol-
cy and practice on a national scale. The policy process
tself and the time it takes is beyond the scope of our
aper.
At the national level we formed an ad-hoc ‘IPTi Core
roup’, which steered the development of the strategy and
ent political support. The group consisted of named, mid-
evel managers, who were more likely than senior managers
o be able to attend meetings and were less likely to be
eplaced. The group comprised representatives from the
ational EPI programme, the National Malaria Control Pro-
ramme (NMCP) and from the Integrated Management of
hildhood Illnesses (IMCI) unit of Reproductive and Child
ealth (RCH) department of the MoH. WHO and UNICEF rep-
esentatives were also invited to Core Group meetings. The
ore Group guided the development of a training curricu-
um for front-line health workers, and training materials,
nd advised on who should be trained from each facility,
here and by whom. They also provided a critical review of
raft behaviour-change communication materials and took
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activities undertaken, timeline and stakeholders’ involvement a
part in piloting and training of district-level trainers. The
overall result was an IPTi strategy readily integrated into,
and accepted by, the health system.
National-level stakeholder meetings were conducted reg-
ularly and involved additional staff from the EPI, NMCP and
RCH/IMCI, WHO and UNICEF country ofﬁces, as well as staff
from the Health Management and Information System, Med-
ical Stores Department, Central Transport Unit of the MoH,
the Tanzania Food and Drug Authority, National Bureau of
Statistics, National Institute for Medical Research, Muhim-
bili University College of Health Sciences and the Centre
for Enhancement of Effective Malaria Interventions. Progress
and plans, concerns and criticisms were shared with this
group, and the IPTi strategy was further strengthened as
a result. Although regional medical ofﬁcers and RCH staff
sometimes joined national stakeholder meetings, a series
of planning and feedback meetings were held at regional
and district levels during strategy development. These pro-
vided a wealth of useful, practical feedback on strategy
development, communication and training materials and
approaches to documentation and delivery of IPTi.
All through strategy development we considered only
options that could be sustained on a public health scale,
by existing front-line health staff, without ongoing inputs
from the research team. For example, we did not use com-
munity sensitization and mobilization through street theatre
or mass outreach campaigns because the costs are likely to
be prohibitive in the context of routine implementation by
the health system. Preparation for implementation involved
two sets of activities. The ﬁrst consisted of the development
and testing of a brand name, messages of awareness-raising
posters and a health-staff training programme, with rele-
vant support materials. The second led to the development
of management systems for IPTi, which were incorporated
into the routine health system.
v
y
t
o
cof intermittent preventive treatment in infants (IPTi) — the
nteractions.
.3. Posters and training programme
rapid ethnographic study provided inputs for the
ehaviour-change communication strategy, including deliv-
ry channels, materials and a brand name for IPTi (A. Mushi
t al., unpublished data). In brief, socio-cultural informa-
ion was collected on local messages on perceptions of
alaria and anaemia, vaccination clinics, attitudes to SP
s a drug to prevent and treat malaria, and communi-
ation channels for health issues. A brand name for IPTi
nd draft materials were pre-tested in focus groups and
n-depth interviews at village level, as well as in individ-
al consultations with national, regional and district health
taff as well as other stakeholders. The rapid ethnographic
tudy revealed that mothers mostly learn about health
ssues from health workers and through informal discussions
ith other women. The existing posters at health facili-
ies were seldom referred to by mothers. Nevertheless, we
eveloped two posters promoting IPTi for use in health facil-
ties, with the aim of guiding front-line health staff and
others about key IPTi messages as well as providing a
ocus for health education to mothers attending vaccina-
ion clinic. The soliciting of comments on the draft materials
as a useful mechanism to engage stakeholders at all lev-
ls.
We chose the brand name MKINGE (a Swahili word liter-
lly meaning ‘protect him or her’) and the slogan MKINGE
toto wako dhidi ya malaria (‘protect your baby against
alaria’). One of the posters showed a queue of happy
omen waiting for a nurse to give IPTi to their baby at a
accination clinic. The two captions translated into ‘Protect
our baby from malaria’ and ‘MKINGE is a strategy to give SP
o babies when they are given vaccines at 2, 3 and 9months
f age’. The second poster showed a healthy mother and her
hild in a rural setting and was captioned ‘MKINGE reduces
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alaria and anaemia’ and ‘Many children have already used
KINGE’. The posters bore the logos of the key stakehold-
rs, including the MoH, and the Ifakara Health Research and
evelopment Centre.
.4. Management tools and systems
PTi is administered three times during the ﬁrst year of
ife, at the same time as vaccines delivered by the EPI sys-
em. It thus makes good sense to take advantage of the
ell-developed, tried and tested and widely understood
PI management systems. Forecasting the number of doses
f SP for IPTi was based on the EPI tool used to forecast
he number of doses of DPT vaccine, which is also admin-
stered three times in the ﬁrst year of life. Although the
esearch project supported implementation and delivered
P for IPTi to the district level, the Core Group planned
ow SP for IPTi would follow the same delivery channel from
ational to regional level as the syringes supplied for vac-
ination. This approach ensured that the correct number
f SP doses were supplied but without making additional
emands on the relatively expensive cold chain for vaccine
upply. The required numbers of doses of SP would be deliv-
red to regional vaccine stores in response to their requests.
similar ‘pull’ approach was employed from regional to
istrict vaccine stores and to individual health facilities.
elivery to health facilities of SP for IPTi was thus linked to
elivery of routine vaccines, subject to the same account-
bility controls and the responsibility of the District Cold
hain Ofﬁcer. The minimum and maximum stock levels
ere set in the same way as for vaccines (a minimum of
month’s supply and a maximum of 3 months’ supply). At
ach facility the drugs were signed for in a ledger used
or all other drug and vaccine stocks, and updated to show
tock used each day. At facility level, the person in charge
f the RCH clinic would be given responsibility for IPTi,
ncluding the safe storage of drugs. It was decided that
PTi drugs should not be in the care of the overall facil-
ty in-charge to ensure that SP for IPTi would be available
ven if the facility in-charge was away. Labelled plastic
oxes were given to each facility for storage of SP for
PTi.
The administration of a dose of SP for IPTi was recorded in
hree places. Firstly, the routine tally sheet, which records
he numbers of each vaccine administered, was edited to
ncorporate a section for IPTi. Secondly, the child’s health
ard was also edited so that dates of IPTi doses could be
ecorded in the same area as the routine vaccinations.
hirdly, the register of children regularly attending the facil-
ty, which includes space to document some of the routine
accinations, was also amended to enable recording of doses
f IPTi. In practice, the tally sheet is used as the basis for
monthly summary of the numbers of doses of the differ-
nt vaccines administered. A speciﬁc ‘EPI monthly report’
s completed in each facility and sent to the District Cold
hain Ofﬁcer, whose responsibility is to complete a monthly
ummary report of all facilities in the district and forward to
he Regional Cold Chain Ofﬁcer, who completes and forwards
o national level. By incorporating IPTi into each summary
heet, a system to account for IPTi, and to estimate cover-
ge, was established.
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.5. Implementation of the IPTi strategy
he decentralized health system in Tanzania means that
ealth service delivery is the responsibility of District Coun-
il Health Management Teams (CHMTs). As part of the IPTi
trategy, the research team seconded from a CHMT an ‘IPTi
roject implementation coordinator’: a Clinical Ofﬁcer with
ublic health experience. In conjunction with CHMT mem-
ers, he organized the training sessions, mobilized district
nd regional health staff for training and later supported
mplementation of the IPTi strategy in the ﬁve districts.
ther project staff with direct experience of IPTi and devel-
pment of other public health strategies, provided technical
upport. Implementation of IPTi was done in a phased
pproach, with health facility staff in half of all divisions
a division being an administrative level below a district)
eing selected randomly for training to implement IPTi. This
luster-randomized approach allowed robust evaluation of
he IPTi strategy. Thus, staff from a randomly selected half
f all health facilities were trained to implement IPTi in early
005.
In an initial phase, lasting about 1 month, the IPTi strat-
gy was piloted in two health facilities. After this, messages
nd materials were ﬁnalized and plans made for regional
taff to train district health staff as trainers, and for the
istrict staff in turn to train the front-line health staff as pri-
ary implementers. Materials developed to support training
nd implementation included an ‘IPTi guideline’ booklet,
eveloped to guide the training of health workers and con-
isting of an overview of IPTi, a section with step-by-step
nstructions on how to administer and record doses of IPTi
nd a set of frequently asked questions. A laminated, A3-
ized job aid contained the step-by-step instructions andwas
ntended for use in health facilities, either on the nurse’s
able or on a wall in the vaccination area. An initial stock
f SP tablets for IPTi, posters, modiﬁed child health cards
nd tally sheets were also supplied during initial training, as
ere adhesive stickers to enable recording of IPTi doses on
he child health cards of children who had already received
ealth cards but who would become eligible for a dose of
PTi.
Piloting was started by a team formed by the project
mplementation coordinator, two other members of the
roject team, an NMCP representative, the Regional Repro-
uctive and Child Health Coordinator from each of the two
egions, one District Medical Ofﬁcer, one District Reproduc-
ive and Child Health Coordinator, and one District Cold
hain Ofﬁcer. This team reviewed the training guidelines
nd discussed operational issues such as the management
nd storage of IPTi supplies at district and facility levels.
he majority of health facilities in the area had no supply of
lean water, and after discussion with CHMT, it was decided
o encourage health staff to purchase a socially marketed
hemical puriﬁcation liquid (WaterGuard, Mukwano Indus-
ries, Kampala, Uganda), and also to buy cups and spoons
here necessary, using funds generated from user charges..6. Training of health staff
ne day of training for six staff from each CHMT was done in
ach region, led by the two Regional Reproductive and Child
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Health Coordinators with technical support from the IPTi
project implementer, two other members of the research
team and a member of the NMCP. From each district, the Dis-
trict Medical Ofﬁcer, District Reproductive and Child Health
Coordinator, District Cold Chain Ofﬁcer, Pharmacist, Nurs-
ing Ofﬁcer and malaria focal person attended the training.
Regional medical ofﬁcers, pharmacists and cold chain ofﬁ-
cers were also invited. Training included lectures, group
discussions, practical work and a test of understanding. Fol-
lowing a general introduction a step-by-step explanation
of how to administer and document IPTi was given. Before
administering IPTi, health workers were reminded to check
whether children had ever had an adverse reaction to any
sulphur-containing drug such as co-trimoxazole or SP, and
also whether they had received SP for malaria treatment in
the previous 2 weeks, in order to avoid giving IPTi to those
children. Other issues covered included how to order SP for
IPTi, storage of SP, distribution and tracking within each dis-
trict, supervision of IPTi activities and plans for training in
each district. It was agreed that IPTi supervision would fol-
low the same procedures as EPI vaccines, with district EPI
staff (District Cold Chain Ofﬁcer or District Reproductive and
Child Health Coordinator) being responsible for delivery of
supplies to each facility, checking stock, reviewing record-
keeping and supporting front-line health workers. Materials
for training included the guideline booklet, job aid, posters,
modiﬁed child health cards, stickers to record IPTi doses on
the child health cards of children who already had cards,
the modiﬁed vaccine tally sheets and stickers for modiﬁca-
tion of the village child health register. An initial stock of SP
tablets for IPTi was also given to trainees.
In the weeks that followed, 115 front-line health staff
from 61 dispensaries, health centres and hospitals attended
the one-day training course. The training approach followed
that used to train the trainers but with more empha-
sis on practical activities: why, when, how and to whom
IPTi should be administered, storage, record-keeping and
problem-solving. The training was led by three members of
the CHMT (District Medical Ofﬁcers, District Reproductive
and Child Health Coordinators and District Cold Chain Ofﬁ-
cers) under the observation and technical support of the IPTi
Project Implementation Coordinator. Two participants were
invited from each health facility: the overall in-charge and
the in-charge of the RCH section of the facility. The over-
all in-charge was included so that they would support their
RCH staff to administer IPTi and would know to check before
prescribing SP to a young child.
As part of the training, an initial supportive supervi-
sion visit was made to all participating health facilities
within the following 2 months. District EPI staff and the
IPTi Project Implementer reinforced the key messages of
the one-day training session and helped to solve any prob-
lems. By October 2006, 92% of facilities (57/62) had started
to use WaterGuard. A few of the front-line staff did not
start implementation until after this visit, some waiting to
start implementation at the beginning of a month, others
wanting reassurance and beneﬁting from an on-site demon-
stration to reinforce the training on the new intervention.
The main issues identiﬁed related to secure storage of the
SP and adequate documentation.
After these initial visits, subsequent IPTi implementa-
tion management and support was fully integrated into the
d
w
a
p
rigure 2 Intermittent preventive treatment in infants (IPTi)
t health facilities, stock-outs and supplies of IPTi that were
elivered to the facility at the same time as vaccines.
outine CHMT systems. The IPTi Project Implementer would
ometimes join CHMT members during their routine monthly
upervision visits in such a way that he visited most facilities
very 2 months. Stock-outs of IPTi were a relatively com-
on problem, found at roughly 13% of all visits. In the early
onths, vaccines were sometimes delivered without SP for
PTi, but as implementation continued the stock was increas-
ngly distributed with vaccines (Figure 2). Coverage of each
ose of IPTi at each facility each month was estimated
sing the number of children recorded on the tally sheet
s the numerator and the established denominator based on
he estimated population aged 0—11 months in the facility
atchment’s area (4% of the population from the 2002 cen-
us, with adjustments for annual population growth, divided
y 12 to get a monthly target population). Data were com-
iled at district level to generate estimates over multiple
acilities or for larger periods of time; for example, in the
rst quarter of 2006, coverage of dose 3 of IPTi for imple-
enting divisions of Newala District was 79% (363/462) and
or implementing divisions of Tandahimba District was 78%
594/764).
Nine months after the start of implementation we did
ualitative and time-and-motion studies of RCH nurses deliv-
ring EPI vaccines and/or IPTi. The aim was to assess
cceptability of IPTi to facility staff and to document the
mpact on time use of the new IPTi intervention. We did
n-depth interviews with the nursing staff, exploring their
xpectations of IPTi implementation (for nurses in compar-
son divisions) or their actual experience of implementing
PTi (nurses in non-IPTi implementing, comparison divisions).
airs of interviewers spent a week at each participant health
acility. Towards the end of their stay, when the staff had
rown used to the presence of the interviewers, the health
orkers were followed on a typical vaccine clinic day. Fol-
owing positive earlier experiences with the use of personal
igital assistants (PDAs) to capture health research data,26e used PDAs to document the responses to direct questions
nd the time taken to give out IPTi health education and pre-
are and administer IPTi to infants, and the time taken to
ecord delivery of the IPTi doses on immunization cards and
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MIS books. This was done by means of a menu of nurses’
ctivities on the PDA; when an activity was selected, the
ime was automatically recorded as the start time for that
ctivity and the end time for the previous activity. The data
ere thus entered directly into Pendragon forms (Pendragon
oftware Corp., Libertyville, IL, USA) and synchronized into
n Access database (Microsoft Corp., Redmond, WA, USA),
here they were cleaned before analysis using Stata, version
(Stata Corp., College Station, TX, USA).
A total of 24 health facilities were sampled in the ﬁve
tudy districts, selected to ensure balance in terms of type
f health facility (dispensary or health centre), number of
accinating staff and vaccine coverage between facilities
n IPTi intervention and comparison areas. In comparison
reas, when health workers were asked how difﬁcult they
hought it would be to implement IPTi, most said they were
eady to implement, although a few were apprehensive
bout the anticipated increased work load and small num-
er of staff. However, nurses in implementation areas said
hey had experienced no major difﬁculties in implement-
ng IPTi. There were no reports of changes to the work
chedules and only a few mentioned an obvious increase
n the time spent on documentation. Among the 12 inter-
ention facilities, nine had vaccination days with children
ligible for IPTi. RCH nurses spent a median of 12.4min
n = 9, range 1.6—28.9) on IPTi delivery and dose-recording
n a typical vaccine clinic day. There was a median of
ore than 2 h non-productive time among nurses on these
accine clinic days in both implementing and comparison
acilities.
.7. Financial costs
he study in southern Tanzania included tracking of health
ystem and other costs of developing the strategy and
aintaining routine implementation of the strategy in ﬁve
istricts, which are described elsewhere.27 Brieﬂy, the esti-
ated ﬁnancial cost to start up and run IPTi in the whole
f Tanzania in 2005 was US$1,486,284. Start-up costs of
S$36 363 were incurred at the national level, mainly on
he development of behaviour-change communicationmate-
ials, stakeholders’ meetings and other consultations. The
nnual running cost at national level for intervention man-
gement and monitoring and drug purchase was estimated
t US$459 096.
. Discussion
nder the auspices of the IPTi Consortium11 and other
roups, IPTi safety and efﬁcacy studies have been com-
leted or are ongoing in Ghana, Gabon, Mozambique, Kenya,
anzania and Papua New Guinea (PNG), and large-scale,
ulti-district implementation of IPTi is ongoing in six coun-
ries under programmes run by UNICEF. The end product will
e a detailed safety proﬁle and an overview of the efﬁ-
acy of IPTi from a range of epidemiological and geographic
ettings. Furthermore, the Consortium will have generated
xperience in the development and operationalization of
PTi strategies in a variety of health systems. Hence, it will
e possible to make an evidence-based policy decision and
hen, if the recommendation is to push forward with IPTi,
a
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o facilitate rapid, large-scale implementation and public
ealth action.
We have described the development and early imple-
entation of an IPTi strategy within the context of a
arge-scale operational research programme in southern
anzania. Broad institutional and political support were gar-
ered through stakeholders meetings at various levels and
elped to assure the integration of the IPTi strategy into
xisting service delivery.28 The Core Group was an efﬁcient
echanism to develop a robust strategy by accessing the
dvice of key stakeholders on the development and ﬁne-
uning of the delivery system. The establishment of this
roup helped maintain awareness and involvement in the
rocess of strategy development, which has previously been
hown to be vital in determining the longer-term utility of
health strategy.29 Researchers worked in partnership with
oH representatives to deliver a new intervention over a
arge area in a way that could readily be scaled up nationally.
n so doing, we have tried to translate research ﬁndings into
omething that could be applied as public health action.30
he study had an external clinical monitor for quality assur-
nce. Among the lessons learned in this process are that
onsiderable time is needed to prepare for public health
ction, in addition to evidence of beneﬁt, a collaborative
pproach and adequate ﬁnancial resources.
Delivery of IPTi through well-established routine systems
uch as EPI also increases the chance of long-term sustain-
bility, saves on implementation costs and should make the
pproach relatively attractive to policy-makers. The ini-
ial activities described here have generated information
n costs and experience with the issues surrounding drug
upply, training, supervision and development of implemen-
ation guidelines that could speed up implementation at
ountry level. The EPI is unparalleled in its ability to deliver
reventive interventions to young children in Africa. In its 30
ear existence the EPI has developed into a well-respected
ertical programme at national level, which is fully inte-
rated with other health services at district level and at the
oint of service delivery. Coverage ﬁgures in Tanzania show
hat 71% of all children aged 12—23 months have received
ll their routine vaccines by the age of 12 months, and 96%
f children have received at least one vaccine.23
Our coverage estimates are based on routine reporting
nd should be treated with the caution normally associated
ith such estimates, as both numerator and denominator are
rone to errors. The number of children who have received
he intervention is recorded on a simple tally-sheet, and
ith this approach it is easy to record the same child twice
nd to forget to record other children. The target popula-
ions are also prone to errors due to temporary or permanent
n and out migration, seasonal variation in births and dif-
culty deﬁning target populations. Nevertheless, routine
stimates of vaccine coverage match relatively well with
stimates derived from a household survey in the same
rea.25
Our IPTi strategy is embedded within a research study,
nd hence the conditions under which IPTi is implemented
re not exactly as they would be in a national programme.
PTi is not implemented in all health facilities, but in a ran-
omly selected half of the divisions. Although this detracts
rom the ‘real-life’ nature of the implementation it adds
onsiderable strength to the evaluation. The full-time IPTi
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Project Implementer accompanied CHMT members on visits
to health facilities about every 2 months, probably increas-
ing the frequency and focus of IPTi-related activities during
routine supervision visits. This may have increased IPTi
coverage beyond that gained by a national programme,
although follow-up visits were in the context of routine
supervision by CHMT members and the approach mirrored
routine implementation on a national scale.
After one full year of implementation, IPTi was nearly
always distributed from district to facility level at the same
time as routine vaccines, suggesting that district health staff
had integrated IPTi into their usual routine. However, stock-
outs of IPTi remained relatively common. For example, 10%
of health facilities experienced at least one stock-out in the
second quarter of 2006. Although this is of concern, it should
be noted that stock-outs of routine vaccines were at least as
common. For example, a health facility survey done in the
study area in 2004 found that only 77% (91/118) of all facil-
ities had all vaccines in stock on the day of the survey.25
Nevertheless, as most stock-outs were of short duration,
overall vaccine coverage was greater than 80% for DPT and
polio.
Staff in facilities where IPTi was not available expected
to be able to implement an IPTi strategy, although some
expressed reservations about the increased workload. How-
ever, no staff involved in IPTi implementation reported
having to increase the number of vaccination days per
week or reorganization of clinic staff to accommodate
the increased workload. We observed IPTi-related activi-
ties taking a median time of less than 15min per nurse
per vaccination day, and there was no evidence of health
worker time constraining the delivery of IPTi or other
health interventions. We were surprised to ﬁnd that vac-
cinating nurses had a median of over 2 h non-productive
time per vaccination clinic day, although this is similar to
other facility-based time-and-motion studies in Tanzania
and elsewhere.31 Hence, IPTi could be rolled out in an inte-
grated manner throughout the country by the health workers
who are already available. It is important to note that,
although human resources are a major problem in Tanza-
nia and other developing countries, many aspects of health
service delivery could be improved by enhanced time man-
agement and supportive supervision at facility level.
The overall purpose of the southern Tanzania IPTi effec-
tiveness study was to prepare for prompt public health
action when and if a positive policy recommendation is
made. Policy recommendations are not made on the basis
of research evidence alone, but rest on other issues as
well.15,29,32 What are the consequences of an IPTi policy rec-
ommendation being delayed or not being made at all? In this
case implementation would stop, and the lessons described
here would have relevance for the future, for development
of other public health strategies.
In undertaking this work, there were some negative
experiences that need to be documented. Working with gov-
ernment employees at national, regional and district level,
the research team found some individuals did not prioritize
work related to IPTi, possibly because they felt they should
have been paid extra to do it. At service delivery level,
some staff who had received on-the-job training were not
ready to administer IPTi if a colleague who had attended
formal IPTi training was out of the working station. This
R85
eluctance was probably due to envy of formal trainees,
ho had received a travel allowance to attend the training.
upervision was an additional challenge, with infrequent
isits, which were rarely supportive. These problems were
ackled through communication and positive feedback for
he purpose of bringing productive changes in public health
elivery.
In conclusion, this study has generated useful experience
n the development of a strategy for the routine delivery of
PTi. We found that combining researchers and programme
mplementers into a single Core Group enabled the develop-
ent of a practical strategy that was readily implemented
t facility and district level. The researchers led strat-
gy development, and made the major investment in this
espect, thus helping to translate research results into a
trategy that could be implemented as a public health pro-
ramme. We believe this partnership to be novel and hope
hat our experience can contribute to the design of delivery
trategies, not only for IPTi but also for taking to scale other
hild health interventions.
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